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Although NAD+ biosynthesis is required for Sir2
functions and replicative lifespan in yeast, alter-
ations in NAD+ precursors have been reported
to accelerate aging but not to extend lifespan.
In eukaryotes, nicotinamide riboside is a newly
discovered NAD+ precursor that is converted to
nicotinamide mononucleotide by specific nico-
tinamide riboside kinases, Nrk1 and Nrk2. In
this study, we discovered that exogenous nico-
tinamide riboside promotes Sir2-dependent
repression of recombination, improves gene si-
lencing, and extends lifespan without calorie
restriction. The mechanism of action of nico-
tinamide riboside is totally dependent on
increased net NAD+ synthesis through two
pathways, the Nrk1 pathway and the Urh1/
Pnp1/Meu1 pathway, which is Nrk1 indepen-
dent. Additionally, the two nicotinamide ribo-
side salvage pathways contribute to NAD+
metabolism in the absence of nicotinamide-
riboside supplementation. Thus, like calorie
restriction in the mouse, nicotinamide riboside
elevates NAD+ and increases Sir2 function.
INTRODUCTION
In wild-type yeast cells, whose replicative lifespan is lim-
ited by accumulation of extrachromosomal rDNA circles
(ERCs) (Sinclair and Guarente, 1997), Sir2 activity as an
NAD+-dependent protein lysine deacetylase promotes
replicative lifespan (Kaeberlein et al., 1999; Imai et al.,
2000; Lin et al., 2000). Calorie restriction (CR), the most
powerful known intervention to extend lifespan in verte-
brates, extends lifespan in wild-type yeast cells in a Sir2-
and NAD+-dependent manner (Lin et al., 2000). Although
ERCs are a species-specific aging mechanism and
ERC-independent and Sir2-independent processes for
replicative-lifespan extension clearly exist (Kaeberleinet al., 2004), overexpression experiments in worms
(Tissenbaum and Guarente, 2001) and flies (Rogina and
Helfand, 2004) have demonstrated conserved roles for
Sir2-related enzymes (Sirtuins) in animal longevity.
Because of the central roles of NAD+ and its reduced
and phosphorylated derivatives in metabolism (Belenky
et al., 2007), and the conserved functions of Sirtuins in lon-
gevity, much attention has been paid to the mechanisms
of NAD+-dependent regulation of Sir2 in CR-mediated
alterations of metabolism and lifespan. Two leading
mechanisms from yeast molecular biology are that CR
promotes clearance of Sir2-inhibiting nicotinamide (Nam)
(Anderson et al., 2003a) or a decrease in NADH (Lin
et al., 2004), thereby increasing Sir2 function. It was also
proposed that CR might increase the level of the Sir2 sub-
strate, NAD+ (Guarente, 2000). It has now been shown that
in livers of mice fasted for one day, NAD+ levels and Sirt1
protein levels are increased, leading to deacetylation of
PGC-1a and a consequent gluconeogenic transcriptional
program (Rodgers et al., 2005). Additionally, in a murine
model of Alzheimer’s disease expressing the Swedish al-
lele of human Ab precursor (Hsiao et al., 1996), CR almost
completely prevents amyloid neuropathology coincident
with increased Sirt1 protein expression in the neocortex,
increased brain NAD+ levels, and reduced brain Nam
(Qin et al., 2006). Thus, a CR-mimetic small-molecule in-
tervention to improve Sirt1 function would have con-
siderable potential in metabolic and neuroprotective
therapeutic areas. Indeed, evidence has recently been
presented that high-dose resveratrol improves health,
longevity (Baur et al., 2006), and muscle performance
(Lagauge et al., 2006) in overfed mice through a mecha-
nism that appears to involve Sirt1 activation. Although a
nutritional approach of increasing Sir2 activity and longev-
ity would be attractive, this has only been achieved by en-
gineered gene overexpression in yeast (Anderson et al.,
2002) because nicotinic acid fails to extend lifespan and
Nam shortens lifespan (Bitterman et al., 2002; Gallo et al.,
2004). Moreover, extra copies of NPT1 were reported to
activate Sir2 and extend lifespan in a manner mimicking
CR but without increasing NAD+ levels (Anderson et al.,
2002). In fact, although now supported by animal dataCell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc. 473
Figure 1. Schematized Intracellular
NAD+ Synthesis in Eukaryotes
(A) In yeast, NAD+ is synthesized via a de novo
biosynthetic pathway from trp and three sal-
vage pathways from the vitamin precursors,
nicotinic acid, Nam, and NR (Bieganowski
and Brenner, 2004).
(B) As shown in this study, Urh1, Pnp1, and
Meu1 constitute a second salvage pathway
for NR utilization, which is merged into Nam
and nicotinic-acid salvage.
(C) The presumed vertebrate intracellular path-
ways for NAD+ synthesis are shown. Vertebrate
intracellular NAD+ metabolism differs from fun-
gal NAD+ metabolism by the addition of PARP
as an NAD+ consumer, the use of Nam PRTase
(PBEF) instead of nicotinamidase (Pnc1), and
the encoding of Nam N-methyltransferase
(NNMT) activity.(Rodgers et al., 2005; Qin et al., 2006), the idea that Sir2
might be activated by increased NAD+ (Guarente, 2000)
seems to have been set aside in light of the fact that at
least four studies did not observe increased NAD+ either
in CR conditions or when a biosynthetic gene was overex-
pressed (Lin et al., 2001; Anderson et al., 2002; Anderson
et al., 2003b; Lin et al., 2004).
Our investigation of NAD+ synthesis continues to indi-
cate that not all of the metabolic steps for the molecule
discovered 100 years ago as cozymase (Harden and
Young, 1905) have been identified genetically, even
though tryptophan, nicotinic acid, and Nam were identi-
fied as biosynthetic precursors long ago (Krehl et al.,
1945). Accordingly, the lack of a complete set of genes
controlling NAD+ metabolism may be hampering mecha-
nistic analysis of Sir2-dependent and NAD+-dependent
functions in all eukaryotic models under study. Recently,
we discovered that nicotinamide riboside (NR), a natural
product present in milk, is an NAD+ precursor that is con-474 Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc.verted to NAD+ through the action of conserved eukary-
otic NR kinases including yeast and human Nrk1 and hu-
man Nrk2 (Bieganowski and Brenner, 2004). As shown in
Figure 1A, the de novo pathway from tryptophan, the
nicotinic-acid import/salvage pathway, and the yeast
Nam salvage pathway all depend on the action of gluta-
mine-dependent NAD+ synthetase Qns1 (Bieganowski
et al., 2003). Thus, provision of extracellular NR defined
a novel biosynthetic pathway to NAD+, a pathway that
was shown to be Qns1 independent and Nrk1 dependent
(Bieganowski and Brenner, 2004).
Although NR rescued the growthof yeast cells containing
qns1 gene deletions, it was not clear whether exogenous
NR would contribute to the NAD+ pool in wild-type cells,
whether the Nrk1 pathway to NAD+ promotes Sir2 func-
tions including longevity, and whether there is an Nrk1-in-
dependent route to NAD+. Here, we show that exogenous
NR promotes Sir2-dependent repressionof recombination,
gene silencing, and extension of longevity through the Nrk1
pathway of NAD+ synthesis in yeast npt1 mutants. We dis-
cover a second and Nrk1-independent pathway for NR uti-
lization initiated by Urh1, Pnp1, and Meu1 and establish
that NR salvage pathways are important components of
NAD+ metabolism in the presence and the absence of ex-
ogenous NR. We establish that although yeast cells relying
on de novo NAD+ biosynthesis grow well, they perform
Sir2-dependent gene silencing poorly and age rapidly. Fi-
nally, we show that NR improves gene silencing and lon-
gevity in glucose-replete wild-type cells by a mechanism
that depends on NAD+ synthesis through the Nrk1 pathway
and the Urh1/Pnp1/Meu1 pathway.
RESULTS
NR Increases Sir2-Dependent Repression of
Recombination, Gene Silencing, and Replicative
Lifespan via Nrk1-Dependent NAD+ Synthesis
Earlier studies established that the increase in longevity
observed in calorie-restricted yeast cells depends not
only on Sir2 but also on Npt1, the nicotinic acid phosphor-
ibosyltransferase (PRTase) (Lin et al., 2000). Similarly,
Npt1 has been shown to be required for optimal Sir2-de-
pendent gene-silencing activities (Smith et al., 2000; An-
derson et al., 2002; Sandmeier et al., 2002). As shown in
Figure 2A, we reproduced the requirement for Sir2 (Got-
tlieb and Esposito, 1989) and Npt1 (Smith et al., 2000) in
repressing recombination between repeated ribosomal
RNA genes. Addition of 10 mM NR was sufficient for re-
pressing ribosomal gene recombination in the npt1 strain.
To determine whether NR represses recombination via
a Sir2-dependent mechanism, we tested whether the
hyper-recombinational phenotype of sir2 could be re-
duced by an addition of 10 mM NR. As shown in Figure 2A,
NR was without benefit to the sir2 mutant, establishing
that the target of NR function depends on Sir2.
Repression of recombination within the ribosomal-gene
array has the limitation of being a yeast-specific function
of Sir2. Because regulation of gene expression by virtue
of protein lysine deacetylase activity is the more universal
function of Sirtuins (Sinclair and Guarente, 2006), we
treated wild-type, npt1mutant, and sir2mutant yeast cells
containing a modified URA3 gene (mURA3) integrated at
the ribosomal-gene array (Buck et al., 2002) with increas-
ing concentrations of NR. As shown in Figure 2B, npt1mu-
tants exhibited moderately poor silencing of ribosomal-
gene-integrated mURA3, and this silencing was improved
by addition of 10 mM NR. However, sir2 mutants failed
to silence the rDNA-integrated mURA3 construct, thus re-
sulting in aberrant Ura3 expression not improved by 10 mM
or 1 mM NR.
In view of the subtle, Sir2-dependent defect in rDNA
silencing, exhibited by npt1, that was corrected by NR,
we turned to two robust assays in which NR might benefit
cells, namely subtelomeric silencing and replicative life-
span. Sir2 has well-established roles in silencing genes
at subtelomeric loci (Smith et al., 2000) and promoting
the longevity of wild-type yeast cells (Kaeberlein et al.,Figure 2. Support of Sir2 Functions by Nrk1-Dependent NR
Conversion to NAD+
The hyper-recombination (A) and ribosomal-array gene-silencing (B)
phenotypes of npt1 but not sir2 are suppressed by NR. Correction of
the telomeric-gene-silencing phenotype (C) and low NAD+ content
(D) of npt1mutants by NR depends on Nrk1. (E) shows that NR extends
the lifespan of yeast npt1 mutants on YPD (2% glucose) media.Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc. 475
1999), whose replicative lifespan is limited by the accumu-
lation of ERCs (Sinclair and Guarente, 1997). As shown in
Figure 2C, the npt1 mutant suffers a severe silencing de-
fect such that it expresses a telomere-integrated URA3
construct, resulting in 5-fluoroorotic acid (5-FOA) sensitiv-
ity. This phenotype was suppressed by addition of 10 mM
NR. To address whether the mechanism of NR suppres-
sion of npt1 depends on NAD+ biosynthesis, we intro-
duced an nrk1 mutation into telomeric-silencing reporter
strains that are wild-type and mutant for npt1. Although
the nrk1 mutation on its own did not produce a defect in
telomeric silencing, this mutation produced a synthetic re-
duction in telomeric silencing with npt1 and completely
eliminated the ability to be suppressed by NR.
As shown in Figure 2D, npt1 mutation causes a severe
defect in intracellular NAD+ levels, and this defect is
made somewhat worse by deletion of nrk1. We grew cul-
tures in synthetic dextrose complete (SDC) media and in
SDC supplemented with 10 mM NR and followed cellular
NAD+ concentration by performing acid extractions of nu-
cleotides over the course of growth of liquid cultures. By
using mole amounts of extracted NAD+ to calculate
intracellular concentrations, we determined that NR cor-
rects the deficit in NAD+ of an npt1 strain. Moreover, in
precise agreement with the Nrk1 dependence of NR as
a silencing factor for the npt1 mutant, Nrk1 is required
for the npt1 strain to incorporate NR into NAD+. In the
npt1 nrk1 mutant, NR can neither elevate NAD+ levels
(Figure 2D) nor improve telomeric silencing (Figure 2C).
Earlier, Npt1 function was shown to be required for the
longevity benefit of CR (Lin et al., 2000), and increased
NPT1 copy number was shown to promote longevity with-
out imposition of CR (Anderson et al., 2002). In Figure 2E,
we show that the npt1 mutant reduces longevity in (non-
CR) YPD media from an average replicative lifespan of
20 generations to an average lifespan of 8.3 generations.
Just as NR suppressed the ribosomal DNA recombination
and silencing defects of npt1, addition of 10 mM NR to YPD
suppressed the short lifespan of the npt1 mutant, thereby
extending the average lifespan of this mutant to 16.1 gen-
erations. This is a unique result among NAD+ precursors
because nicotinic acid fails to extend lifespan and Nam
shortens lifespan (Bitterman et al., 2002; Gallo et al.,
2004).
Exogenous NR Boosts NAD+ Levels as Yeast Cells
Deplete Nicotinic Acid
Although NR functions as an Nrk1-dependent silencing
and longevity factor, careful examination of Figure 2D sug-
gested that there are unanticipated complexities in NAD+
metabolism and NR utilization. First, the intracellular NAD+
concentration of a wild-type cell was not stable over the
course of growth in SDC liquid culture. Second, addition
of 10 mM NR to the strain deficient in Nrk1 appeared to
elevate NAD+ levels over the course of growth in liquid
culture (Figure 2D).
To dissect the basis for the instability in NAD+ concen-
tration and to determine how yeast cells containing intact476 Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc.NAD+ biosynthetic pathways incorporate NR into NAD+,
we grew a wild-type yeast strain in SDC and in SDC sup-
plemented with 10 mM NR and followed cellular NAD+ con-
centrations over the course of growth of liquid cultures. As
shown in Figure 3A, the intracellular NAD+ concentration
of a wild-type yeast cell declines from greater than 2 mM
early in the culture to 1.1 mM late in the culture. Inclu-
sion of 10 mM NR stems the progressive decline in intra-
cellular NAD+, but not until an optical density (OD600 nm)
of approximately 2.5 is reached.
Figure 3. Wild-Type Yeast Cells Convert Extracellular NR into
Intracellular NAD+
(A) Intracellular NAD+ concentration is plotted as a function of the cell
density of wild-type yeast cells grown in SDC media (shown in circles)
or SDC supplemented with 10 mM NR. Under these conditions, NR
elevates intracellular NAD+ as cells exceed an OD600 nm of 2.5.
(B) Intracellular NAD+ concentration is followed as a function of cell
density in wild-type cells grown in SDC with and without the 3 mM nic-
otinic acid (Na) in yeast nitrogen base. Without Na, NAD+ concentra-
tions are stable throughout the culture.
(C) The amount of intracellular NAD+ is more than doubled by addition
of 10 mM NR to Na-free SDC, and the high NAD+ concentration is sta-
ble throughout the culture.
Figure 4. A Second NR Salvage Pathway Is Initiated by Urh1 and Pnp1
Intracellular NAD+ concentration was determined in yeast cells of varying genotype in Na-free SDC media (black bars) and in Na-free SDC media plus
10 mM NR (gray bars). Error bars represent 1 SD of the independently determined NAD+ concentrations of different cultures.
(A) Surprisingly, nrk1 cells have only a slight deficit in incorporation of NR into NAD+.
(B) Nrk1-independent NR salvage depends on Pnc1.
(C) Nrk1-independent NR salvage depends principally on Urh1 and secondarily on Pnp1.
(D) Nrk1-independent salvage is restored to a nrk1 urh1 pnp1 mutant by the cloned URH1 and PNP1 genes.Given the four known pathways to produce NAD+ in
yeast (Bieganowski and Brenner, 2004) and the Sirtuin-de-
pendent degradative pathway to Nam (Tanner et al., 2000;
Tanny and Moazed, 2001), we hypothesized that cells pos-
sess homeostatic mechanisms regulating NAD+ levels
such that NR is not utilized when another precursor re-
mains abundant. Because SDC medium was formulated
to contain tryptophan and nicotinic acid but not Nam or
NR (Wickerham, 1946), it was straightforward to determine
whether depletion of tryptophan or nicotinic acid was lim-
iting for utilization of exogenous NR. We inoculated cells
from stationary phase cultures into fresh SDC media and
into SDC media lacking nicotinic acid and followed growth
and intracellular NAD+ levels. As shown in Figure 3B,
whereas stationary cells diluted into SDC increased NAD+
concentration to that of naive cells and then exhibited a
decline in NAD+, cells diluted into SDC media lacking nic-
otinic acid grew well but with a constant low level of NAD+
(0.9 mM) from the beginning of the culture to the end.
Because nicotinic acid is not a necessary supplement
for yeast cells with an intact de novo pathway, we elimi-
nated the complication of nicotinic-acid-dependent
changes in NAD+ concentration. Thus, we grew wild-type
cells in SDC media without nicotinic acid and examinedthe effect on NAD+ levels of supplementation with 10 mM
NR. As shown in Figure 3C, wild-type cells in nicotinic-
acid-free media have a stable NAD+ level that is doubled
by addition of 10 mM NR. Thus, NR is not only a compound
that rescues the otherwise lethal qns1deletion (Bieganow-
ski and Brenner, 2004) or the phenotypes of Sir2-limited
npt1 mutants (Figure 2) but also a vitamin that elevates
intracellular NAD+ levels by 1 mM in wild-type cells, al-
though its contribution to NAD+ accumulation depends
on depletion of nicotinic acid.
Nrk1-Dependent and Nrk1-Independent
Salvage of NR
Although all known functions of NR depend on the pres-
ence of the NRK1 gene or its human homologs NRK1 and
NRK2, the increased levels of NAD+ in nrk1 cells grown
with NR (Figure 2D) led us to ask whether there might
be an Nrk-independent pathway for NR utilization. Ac-
cordingly, we grew wild-type and nrk1 mutant yeast cells
in nicotinic-acid-free media in the absence or presence
of 10 mM NR. Surprisingly, as judged by incorporation of
NR into NAD+, both wild-type and nrk1 mutants substan-
tially increase NAD+ levels when provided with 10 mM NR
in the culture media (Figure 4A). In nicotinic-acid-freeCell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc. 477
media, wild-type cells increase intracellular NAD+ from
0.77 ± 0.04 mM to 1.98 ± 0.04 mM with addition of 10
mM NR, whereas the nrk1 mutant cells increase intracellu-
lar NAD+ level from 0.67 ± 0.05 mM to 1.87 ± 0.09 mM with
addition of 10 mM NR. This experiment suggested the
existence of an Nrk1-independent pathway for salvage
of NR to NAD+.
Nrk1-Independent Salvage of NR Requires
Nicotinamidase
Because Nrk1 is required for NR to support the growth of
qns1 mutants and to improve gene silencing in npt1 mu-
tants, the presence of an Nrk1-independent NR utilization
pathway suggested that Nrk1-independent utilization of
NR produces metabolites that require Npt1 and Qns1 for
maturation. We hypothesized that a second pathway for
salvage of NR is initiated by an enzyme or enzyme con-
verting NR to Nam. Thus, we deleted the PNC1 gene en-
coding nicotinamidase (Ghislain et al., 2002) from wild-
type cells and from an nrk1 mutant strain and measured
the ability of these strains to incorporate NR into NAD+ on
nicotinic-acid-free media. As shown in Figure 4B, whereas
the pnc1 mutant exhibits an increase in intracellular NAD+
from 0.55 ± 0.02 mM to 1.62 ± 0.10 mM with addition of
10 mM NR, the nrk1 pnc1 double mutant is incapable of in-
corporating supplemented NR into NAD+ (0.69 ± 0.02 mM
to 0.61 ± 0.08 mM with addition of 10 mM NR). Thus,
NRK1-independent salvage of NR requires the nicotinami-
dase, Pnc1.
Formally, nicotinamidase might act at either of two
points in an Nrk1-independent NR salvage pathway. The
pathway might be initiated by a nucleoside-splitting activ-
ity that produces Nam, which would be converted to nic-
otinic acid by Pnc1. Alternatively, although there is no pre-
cedent for nicotinamidase acting on a nucleoside, Pnc1
might convert NR into nicotinic-acid riboside, which would
be converted to nicotinic acid by a nucleoside-splitting
activity. We reasoned that if Nrk1-independent salvage
is initiated by a nucleoside-splitting activity that produces
Nam, the silencing ability of an nrk1 pnc1mutant would be
impaired by NR, because of accumulation of Sir2-inhibit-
ing Nam (Bitterman et al., 2002). To test this hypothesis,
we generated a series of strains containing a telomeric
URA3 reporter and performed gene-silencing assays on
SDC lacking nicotinic acid and SDC lacking nicotinic
acid, supplemented with 10 mM NR. As reported earlier
on standard SDC media (Gallo et al., 2004), pnc1 exhibited
poor telomeric silencing on media without nicotinic acid or
Nam (Figure S1 in the Supplemental Data available online).
Although NR improved telomeric URA3 silencing of wild-
type, nrk1 mutant, and pnc1 mutant strains, addition of
NR exacerbated the silencing defect of the nrk1 pnc1
double-mutant strain (Figure S1).
The Second NR Salvage Pathway Requires Urh1
and Pnp1
The glycosidic bond between the Nam and the ribosyl
moieties of NR corresponds to the bond in NAD+ cleaved478 Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc.by Sirtuins, poly(ADPribose)polymerases (PARPs), and
cADPribose synthases. However, because there are no
PARPs or cADPribose synthases in yeast, and Sirtuins
are highly specific for NAD+, we hypothesized that NR is
cleaved to Nam by a nucleosidase. We identified one can-
didate nucleoside hydrolase and two candidate nucleo-
side phosphorylases in the yeast genome. These enzymes
are mechanistically distinct in that nucleoside hydrolases
use water to break the glycosidic linkage, thus producing
the base plus ribose, whereas nucleoside phosphorylases
use phosphate to break the same bond, thus producing
the base plus ribose-1-phosphate.
Urh1 was reported as a uridine- and cytidine-specific
nucleoside hydrolase that is without vertebrate homologs
and that plays a role in salvaging pyrimidine bases (Mitter-
bauer et al., 2002; Kurtz et al., 2002). Meu1 was reported
as methylthioadenosine phosphorylase, involved in the
first step of methionine salvage and repression of ornithine
decarboxylase activity in yeast and human cells (Subhi
et al., 2003). Pnp1 was identified as the yeast homolog
of bovine and human purine nucleoside phosphorylase
(Pnp), which is involved in purine nucleoside degradation
and salvage of purine bases (Lecoq et al., 2001). Inhibition
of human Pnp has been proposed as a means to control T
cell proliferative disorders (Schramm, 2002). Although
in vitro reports dating back more than 50 years state that
NR can be phosphorylyzed by bovine Pnp (Rowen and
Kornberg, 1951; Wielgus-Kutrowska et al., 1997), there
are other reports that NR phosphorylase is a specific en-
zyme, distinct from Pnp (Grossman and Kaplan, 1958;
Imai and Anderson, 1987). Prior to this study, there has
never been an in vivo system in which the potential roles
of hydrolysis or phosphorolysis of NR could be evaluated
in NAD+ metabolism and the identity of the responsible
enzymes determined by genetic criteria.
Deletions of each gene encoding a candidate NR hydro-
lase or phosphorylase were introduced into the nrk1 back-
ground in order to test whether the mutant gene of interest
reduced Nrk1-independent incorporation of NR into
NAD+. As shown in Figure 4C, assays of NAD+ accumula-
tion revealed that meu1 had no detectable effect on NR
utilization. In contrast, urh1 deletion reduced the NR-
dependent increase in NAD+ of an nrk1 mutant by 55%,
and deletion of pnp1 produced a mild but reproducible
22% reduction in the ability of an nrk1 mutant to incorpo-
rate NR into NAD+. Moreover, when pnp1 deletion was
introduced into the nrk1 urh1 strain, virtually the entire
1.2 mM Nrk1-independent increase in NAD+ concentra-
tion was eliminated. Finally, just as the extent of NR incor-
poration into NAD+ on nicotinic-acid-free media is nearly
unaltered by nrk1 deletion (Figure 4A), the extent of NR uti-
lization in a urh1 pnp1 disruption strain (Figure 4C) is not
strikingly altered. This indicates that, in nicotinic-acid-
free media, cells can use either the Nrk1 pathway or the
Urh1/Pnp1 pathway to incorporate NR into NAD+.
The genes encoding Urh1 and Pnp1 were cloned into
centromeric plasmids under the control of their native pro-
moters. As shown in Figure 4D, upon transformation into
Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc. 479the nrk1 urh1 pnp1 strain, the plasmid carrying URH1 re-
stored 127% of the Nrk1-independent NR utilization ability
of an nrk1 strain, consistent with moderate overexpres-
sion. As expected for a minor source of NR utilization un-
der moderate overexpression, the plasmid carrying PNP1
restored 69% of the Nrk1-independent NR utilization abil-
ity of an nrk1 strain. Thus, Urh1 and Pnp1 individually and
collectively function as NR to Nam catabolic enzymes
in vivo for Nrk1-independent synthesis of NAD+ from
NR. Although Urh1 and Pnp1 break down NR, the assays
of Figure 4 establish that Urh1 and Pnp1 initiate from NR
a Pnc1-linked NAD+ synthesis pathway that functions
independently of the Nrk1 pathway of NAD+ synthesis.
NR Salvage Enzymes Are Required to Maintain NAD+
Levels in the Absence of NR Supplementation
Myristyl nicotinic acid (MNa) is a synthetic prodrug form of
nicotinic acid, designed to be made available to cells by an
esterase (Catz et al., 2005). Although one would expect ef-
ficacy of MNa to be limited by expression of the esterase,
one would not term the esterase an authentic NAD+ bio-
synthetic enzyme because MNa is neither an endogenous
metabolite nor a naturally identified vitamin. To address
whether the identified NR salvage pathways represent au-
thentic and endogenous participants in NAD+ metabolism,
we grew wild-type and nrk1 urh1 pnp1 mutant strains in
SDC medium without and with addition of 10 mM NR.
Although the requirement for Nrk1, Urh1, and Pnp1 in uti-
lization of exogenous NR was demonstrated in Figure 4,
Figure 5 illustrates that these enzymes play a highly signif-
icant role in maintaining NAD+ levels in the absence of
supplemented NR. Thus, NR has activities both as a vita-
min (Bieganowski and Brenner, 2004) and as a metabolite
that depend on Nrk1-dependent and Urh1/Pnp1-depen-
dent salvage.
Figure 5. NR Salvage Enzymes Contribute to NAD+ Biosyn-
thesis in the Absence of Supplemented NR
Intracellular NAD+ concentration was determined in wild-type and nrk1
urh1 pnp1 strains in SDC media without and with 10 mM NR supple-
mentation. Surprisingly, strains lacking Nrk1, Urh1, and Pnp1 have
a substantially lower (0.8 mM) NAD+ concentration than wild-type,
suggesting that NR is a normal cellular metabolite.Genetically validated steps in yeast NAD+ metabolism
are depicted in Figure 1B, and the presumed vertebrate
intracellular NAD+ biosynthetic pathways are depicted in
Figure 1C. In addition to Sirtuins as NAD+-consuming en-
zymes, vertebrate cells express NAD+-consuming PARP
and ADPribose transferase activities and exhibit an
entirely different approach to Nam salvage. Rather than
converting Nam to nicotinic acid, vertebrate cells convert
Nam to NMN with a Nam PRTase (Rongvaux et al., 2002).
This would suggest that in vertebrate cells, conversion of
NR to NMN could either be accomplished in one step, via
the Nrk pathway, or in two steps, via expression of a nucle-
oside phosphorylase and Nam PRTase. A competing ver-
tebrate-specific reaction is catalyzed by Nam N-methyl-
transferase (Aksoy et al., 1994), which removes rather
than salvages Nam (Figure 1C).
Either Nicotinic Acid or NR and an Intact Salvage
Pathway Are Required for Telomeric Gene Silencing
In Figure 2, we showed that the Sir2-limited phenotypes of
npt1 mutants are suppressed by exogenous NR in a man-
ner that depends on Nrk1. Because the Nrk1-independent
NR salvage pathway depends on Npt1, it was not possible
to use that system to determine whether Urh1/Pnp1-de-
pendent salvage of NR also promotes Sir2-dependent si-
lencing and longevity functions. In Figure 6, we examined
the silencing of a telomeric URA3 reporter gene in strains
varying in NR salvage enzymes as a function of media
supplementation. On media containing nicotinic acid, all
strains were proficient in silencing the reporter gene as
demonstrated by formation of 5-fluoroorotic-acid-resis-
tant colonies. However, on media without nicotinic acid,
each of the strains, including wild-type, was strikingly de-
fective in silencing the reporter gene. This result is similar
to that observed in Candida glabrata in which subtelo-
meric adhesin gene expression is derepressed in the
absence of nicotinic acid (Domergue et al., 2005). How-
ever, the absence of silencing in nicotinic-acid-deprived
C. glabrata was attributed to lack of de novo NAD+ syn-
thesis. In contrast, our study demonstrates the failure of
yeast strains, which grow and thrive with de novo NAD+
synthesis, to support telomeric silencing without the addi-
tion of a vitamin.
On media containing 10 mM NR, telomeric silencing by
the wild-type and nrk1 and urh1 pnp1 strains was fully re-
stored, apparently because NR is utilized through the Nrk1
pathway in the urh1 pnp1 strain, the Urh1/Pnp1 pathway
in the nrk1 strain, and both NR salvage pathways in the
wild-type strain. We were surprised to observe that NR
supplementation enabled some telomeric silencing in
the nrk1 urh1 pnp1 strain in which virtually all incorporation
of NR was eliminated (Figures 4C and 6). However, by de-
leting meu1 in the nrk1 urh1 pnp1 telomeric-silencing re-
porter strain, we obtained a strain in which NR provided
no improvement in silencing. By titrating NR into the series
of strains, we showed that the nrk1 urh1 pnp1 mutant,
whose incorporation of NR into NAD+ is virtually undetect-
able (Figure 4C), increases telomeric silencing at
Figure 6. NR Improves Telomeric Gene
Silencing through Both Salvage Path-
ways
Whereas all strains were effective in telomeric
gene silencing on media containing nicotinic
acid, all strains, including wild-type, are grossly
defective in telomeric gene silencing on Na-
free media as judged by 5-FOA sensitivity. Pos-
session of either or both NR salvage pathways
is sufficient for restoring telomeric gene silenc-
ing with 1 mM NR. Surprisingly, at 2.5 mM NR
and greater, deletion of meu1 was required to
completely shut down the silencing benefit of
NR even though the nrk1 urh1 pnp1 strain ap-
peared to be completely deficient in NR utiliza-
tion (Figure 4C).concentrations of NR greater than 2.5 mM, whereas strains
of genotype nrk1 and urh1 pnp1 utilizes NR at 1 mM. Thus,
with the sensitive assay of telomeric gene silencing, the
data indicate that Meu1 contributes to Nrk1-independent
NR salvage in a minor way. Moreover, although S. cerevi-
siae differs fromC. glabrata by synthesizing NAD+ de novo
and produces a stable intracellular NAD+ concentration of
0.9 mM without vitamin supplementation (Figure 2), S.
cerevisiae requires either nicotinic acid or NR and an
intact salvage pathway for efficient telomeric silencing
(Figure 6).
NR Is a Longevity Factor
Strains varying in NR salvage were analyzed for replicative
lifespan on synthetic media without nicotinic acid in the
absence and the presence of NR. As shown in Figure 7
and Table 1, on synthetic, 2% glucose media containing
tryptophan and no vitamin, the mean lifespans of strains
were similar. When strains were supplemented with
10 mM NR, the mean lifespans of wild-type, nrk1 mutant,
and urh1 pnp1 mutant strains were extended by
10.6, 4.3, and 5.3 generations, respectively. In contrast,
the mean lifespan of genotype nrk1 urh1 pnp1, which
is severely deficient in NR utilization, was extended by
only 1.2 generations by NR, and the mean lifespan of
genotype nrk1 urh1 pnp1 meu1 was not extended at all.
The data summarized in Table 1 indicate that yeast cells
on YPD media are substantially longer lived than those
depending on de novo NAD+ synthesis; that YPD ex-
tends lifespan in a manner depending on Npt1; and
that NR extends lifespan in a manner that is totally de-
pendent on NR salvage pathways. Whereas either NR
salvage pathway is sufficient for efficient NR-dependent
telomeric silencing (Figure 6), both pathways are required
for the full benefit of NR in extending lifespan (Figure 7
and Table 1).
DISCUSSION
Because Npt1 and Sir2 are required for the increase in lon-
gevity because of CR in wild-type yeast cells (Lin et al.,
2000), there has been substantial interest in dissecting480 Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc.the NAD+-dependent mechanisms by which CR promotes
Sir2 function and in developing therapeutic strategies that
are CR mimetic. Three mechanisms have been sug-
gested. First, it was postulated that CR might increase
NAD+ substrate levels (Guarente, 2000). Second, evi-
dence was presented that CR and certain stresses act
by lowering Nam inhibitor levels (Anderson et al., 2003a).
Third, evidence was presented that CR decreases NADH
levels (Lin et al., 2004). Although the mechanisms are not
mutually exclusive and might be different in particular an-
imal tissues, recent work in the mouse establishes that
a one-day fast increases NAD+ in the liver (Rodgers
et al., 2005) and that CR elevates NAD+ and reduces
Nam in the brain (Qin et al., 2006). Because elevated
NAD+ appears to mediate some of the beneficial effects
of CR, we have focused on interventions that increase
net NAD+ synthesis. To our knowledge, this is the first
study to show that NR elevates NAD+ levels, promotes
Sir2 functions, and extends lifespan.
The experiments performed herein establish a second
NR salvage pathway initiated in yeast cells by the prod-
ucts of the URH1, PNP1, and MEU1 genes. Although
yeast cells can double intracellular NAD+ levels with provi-
sion of either nicotinic acid or NR in the growth media,
there are important differences between the salvage path-
ways of the two vitamins. As shown in Figure 2, nicotinic
acid, which is almost universally used in yeast synthetic
media though not required for S. cerevisiae growth, pro-
duces an intracellular NAD+ level that drops by more
than 2-fold over the course of growth in liquid culture.
NR stably increases intracellular NAD+ levels and extends
lifespan via two distinct metabolic pathways.
The poor gene-silencing activities and rapid aging ex-
hibited by strains grown under conditions in which intra-
cellular NAD+ levels are 1 mM is striking when one con-
siders that the KM(NAD
+) for yeast Sir2 is reported to be
29 mM (Borra et al., 2004), and virtually allKM(NAD
+) values
for Sirtuin reactions are between 5 and 500 mM (Sauve
et al., 2006). Regulation of Sirtuins in the cell by increase
of NAD+ from 1 mM toward 2 mM can be explained if
most of the ‘‘first mM’’ of NAD+ is protein bound, such
that there is a minimal amount of free NAD+. Our data
Figure 7. NR Extends Lifespan
Yeast strains of (A) wild-type, (B) nrk1, (C) urh1 pnp1, (D) nrk1 urh1 pnp1, and (E) nrk1 urh1 pnp1 meu1 genotypes were subjected to replicative-lon-
gevity assays on nicotinic-acid-free media without and with 10 mM NR supplementation. NR extended average lifespan 10.6, 3, 3.1, and 1.2 gener-
ations, respectively, in the wild-type, nrk1, urh1 pnp1, and nrk1 urh1 pnp1 strains. Extension of lifespan by NR was abolished in the nrk1 urh1 pnp1
meu1 strain. Thus, NR functions as a longevity factor for wild-type yeast by increasing NAD+ synthesis through both NR salvage pathways.suggest that whereas the first mM of NAD+ fulfills essential
functions through NAD+-dependent oxidoreductases, the
second mM fuels discretionary functions of improved
Table 1. Average Replicative Lifespans of Yeast
Strains as a Function of Media
YPD YPD + NR SDC  Na SDC  Na + NRa
Wild-type 20.0 20.4 12.5 23.1
npt1 8.3 16.1
nrk1 22.5 23.9 15.0 19.3
urh1 pnp1 12.5 17.8
nrk1 urh1
pnp1
12.3 13.5
nrk1 urh1
pnp1 meu1
12.4 11.7
a Na, nicotinic acid; NR, 10 mM nicotinamide riboside.gene silencing, reduced rDNA recombination, and in-
creased lifespan.
Eukaryotic NR kinases are highly specific enzymes
that appear to specialize in NAD+ synthesis (Bieganowski
and Brenner, 2004). In contrast, the second NR salvage
pathway is initiated by multifunctional nucleoside catab-
olizing enzymes. Urh1, which has homologs in fungi and
protista (Degano et al., 1996; Shi et al., 1999), is not only
the major enzyme responsible for Nrk1-independent NR
utilization but also the enzyme that S. cerevisiae uses to
salvage pyrimidine bases from pyrimidine nucleosides
(Mitterbauer et al., 2002; Kurtz et al., 2002). Urh1 homo-
logs in protozoan parasites have been proposed as drug
targets because Leishmania and Crithidia do not encode
enzymes for de novo synthesis of purine nucleotides
(Degano et al., 1996; Shi et al., 1999). If these enzymes
are also involved in salvage synthesis of NAD+ from
NR, an inhibitor of the parasite nucleoside hydrolase
might inactivate two pathways enzymologically distinctCell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc. 481
from those of mammalian hosts. Pnp1 and Meu1 play
lesser roles in synthesis of NAD+ from NR in yeast. How-
ever, because human Pnp is highly expressed in lym-
phoid tissues (Markert, 1991) and NRK1 and NRK2
gene expression may be variable, it is possible that
phosphorylases play significant roles in human NAD+
metabolism in some tissues.
Because phosphorolysis of NR to a Nam product would
compete with phosphorylation of NR to an NMN product,
phosphorolysis also has the potential to be destructive to
NAD+ signaling. This is the case because Nam produced
by phosphorolysis can be either converted to NMN by
action of Nam PRTase or cleared by methylation to
N-methylnicotinamide; it can also accumulate and poten-
tially inhibit Sirtuins and PARPs. One would expect that
production of Nam and then conversion to NMN (Revollo
et al., 2004) would be constructive to NAD+ signaling,
whereas conversion to N-methylnicotinamide or accumu-
lation of Nam would inhibit NAD+ signaling. Thus, there
may be conditions in which application of a Pnp inhibitor
(Lewandowicz et al., 2003) with NR may improve the met-
abolic efficacy of NR by shunting the precursor into the
Nrk pathway.
Vitamins are small molecules that are required in diets to
prevent malnourishment. Metabolites are compounds
that are naturally produced in particular biosynthetic path-
ways. Data presented in this study and in a previous study
(Bieganowski and Brenner, 2004) establish the vitamin
functions of NR in yeast. New data establish the role of
NR salvage enzymes in maintaining NAD+ homeostasis
in nonsupplemented cells. NR appears to be unique
among NAD+ precursors in stably elevating NAD+ levels
in yeast and may have advantages in human systems in
which activation of Sirtuins is desired. Indeed, providing
supplements to boost NAD+ synthesis may be a therapeu-
tically important treatment modality for neurodegenerative
conditions stemming from chemotherapy (Araki et al.,
2004), physical nerve damage (Wang et al., 2005), Alz-
heimer’s disease (Qin et al., 2006), and multiple sclerosis
(Kaneko et al., 2006). In ex vivo experiments to protect
dorsal-root-ganglion neurons from transection-induced
axonopathy, the combination of Nam plus overexpression
of Nam PRTase and the combination of nicotinic acid
plus overexpression of nicotinic acid PRTase had neuro-
protective activity. However, NR was the only nonphos-
phorylated, drug-like NAD+ precursor to protect DRG
neurons from axonopathy without concurrent gene ther-
apy (Sasaki et al., 2006). This appears to be because
Nrk2 transcription is induced by nerve damage (Sasaki
et al., 2006).
In addition to the potential value of increased NAD+ syn-
thesis in neuroprotection, genetic and pharmacological
data validate increasing Sirt1 activity in the effective me-
tabolism of a high-fat diet (Lagauge et al., 2006). Because
nicotinic acid causes flushing through a receptor mecha-
nism unrelated to NAD+ synthesis (Benyo et al., 2005) and
Nam inhibits Sirtuins (Bitterman et al., 2002), it will be im-
portant to test whether increasing net NAD+ synthesis with482 Cell 129, 473–484, May 4, 2007 ª2007 Elsevier Inc.NR is as effective in promoting health of vertebrates as it is
in extending lifespan of S. cerevisiae.
EXPERIMENTAL PROCEDURES
S. cerevisiae Strains, Plasmids, and Media
Yeast strains used for measuring NAD+ levels and longevity were de-
rivatives of BY4742 prepared by ourselves or by the deletion consor-
tium (Winzeler et al., 1999) and verified herein. Yeast strains used for
measuring rDNA recombination and silencing were derivates of
JS306 (Smith et al., 1999) and YSB348 (Buck et al., 2002), respec-
tively. Yeast strains used for measuring telomeric silencing were deriv-
atives of YCB647 (Smith et al., 2000). Genetic deletions were intro-
duced by direct transformation of PCR products (Brachmann et al.,
1998) or crosses and tetrad dissection as described in the Supple-
mental Data. Plasmids encoding URH1 and PNP1 were made as de-
scribed in the Supplemental Data. Yeast media and transformations
were prepared as described (Burke et al., 2000) except that, when in-
dicated, yeast nitrogen base (Wickerham, 1946) was prepared without
nicotinic acid and/or with 10 mM NR, which was prepared as de-
scribed (Bieganowski and Brenner, 2004). For elimination of NMN
and Nam impurities, NR was HPLC purified on a strong anion ex-
change column with a 10 mM Na phosphate monobasic running
buffer.
Calculation of Intracellular NAD+ Content
Yeast cultures were grown with agitation in 0.5 l cultures. During
growth, the OD600 nm of 1:10 diluted cells were recorded and 20 ml cul-
tural volumes were pelleted, washed with water, repelleted, and frozen
at 80C. Cell pellets were extracted in 250 ml of ice-cold 1 M formic
acid saturated with butanol. After 30 min, 62.5 ml of 100% (w/v) tri-
chloroacetic acid was added to each extract, and the samples were al-
lowed to precipitate on ice for 15 min. Samples were microcentrifuged
for 5 min, and the acid soluble supernatants were recovered. Pellets
were washed with 125 ml of 20% TCA and repelleted. First and second
supernatants were pooled and measured volumetrically. In three 1 ml
cuvettes, reactions were assembled containing 10 ml 5 mg/ml alcohol
dehydrogenase (two samples) or 10 ml water (control sample), and this
was followed by addition of 840 ml 360 mM Tris (pH 9.7), 240 mM lysine,
0.24% (v/v) EtOH, and finally, 150 ml extract. After a 5 min incubation at
room temperature, the spectrophotometer was zeroed against the
control sample for determining the alcohol dehydrogenase-dependent
increase in absorbance at 340 nm of the duplicate reactions. Mean net
absorbances were converted to molar NAD+ with the extinction coef-
ficient of NADH (6220 M1 $ cm1). Molar NAD+ in the cuvette was con-
verted to molar NAD+ in the extract by a factor of 6.67. Moles of NAD+
in the extract were determined from the fraction of the extract assayed.
To determine the intracellular volumes corresponding to the extracts
and the corresponding intracellular NAD+ concentrations, we used
a nonlinear conversion between the 1:10 diluted OD600 nm values
and the cell number (Burke et al., 2000) and took the volume of a hap-
loid cell to be 7 3 1014 l (Sherman, 1991). For cells grown in media
containing nicotinic acid, NAD+ concentrations were determined, in
duplicate, 6 to 18 times during the growth of a liquid culture. For cells
grown in media without nicotinic acid, the cells were taken with 1:10
diluted OD600 nm values of 0.095–0.105, and the NAD
+ concentrations
were determined, in duplicate, from three to eight independent cul-
tures.
Recombination, Silencing, and Aging
Assays of rDNA recombination and rDNA silencing were performed as
described (Smith and Boeke, 1997). Assays of telomeric silencing
(Smith et al., 2000) and replicative lifespan were performed as de-
scribed (Kennedy et al., 1994), with at least 50 virgin mothers per
strain, with careful control of plate osmolarity.
Supplemental Data
Supplemental Data include additional Experimental Procedures, one
figure, and two tables and can be found with this article online at
http://www.cell.com/cgi/content/full/129/3/473/DC1/.
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